e.g. Tata motors, Reliance MF, 500570

Announcements   for Piramal Pharma Ltd

16 May Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome announcement
15 May Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome announcement
14 May Announcement under Regulation 30 (LODR)-Dividend Updates announcement
14 May Announcement under Regulation 30 (LODR)-Change in Directorate announcement
14 May Announcement under Regulation 30 (LODR)-Press Release / Media Release announcement
14 May Announcement under Regulation 30 (LODR)-Investor Presentation announcement
14 May Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March, 2025 announcement
14 May Board Meeting Outcome for Outcome Of Board Meeting Of Piramal Pharma Limited ('Company') Held On 14Th May 2025 announcement
12 May Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ('SEBI Listing Regulations') - Capacity Expansion Of Lexington And Riverview Sites announcement
12 May Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') -Successful Closure Of US FDA Inspection At Piramal Pharma'S Manufacturing Facility Located At Turbhe announcement
View announcements for all companies Next >

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback